Though agents found blatant fraud in a Houston lab, the FDA refused to question drug safety.
In a second case of flawed drug research, FDA response was slow and secretive.
Did a company try to hide risks of MRI dye Omniscan?
The best remedy is transparency.
A personal encounter with the complexity and errors of the modern healthcare system.
Journalist Mina Kimes discusses illegal drug experiments and medical catastrophe.
“Toxic Beauty,” a retrospective at NYU’s Grey Gallery, brings together the writing and visual work of an extraordinarily socially engaged artist.